These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

290 related items for PubMed ID: 18234309

  • 1. The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis.
    Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S, Heeg K, Werfel T, Renz H.
    J Allergy Clin Immunol; 2008 Apr; 121(4):1013-9. PubMed ID: 18234309
    [Abstract] [Full Text] [Related]

  • 2. Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: impact of the TLR-2 R753Q polymorphism.
    Niebuhr M, Langnickel J, Draing C, Renz H, Kapp A, Werfel T.
    Allergy; 2008 Jun; 63(6):728-34. PubMed ID: 18445187
    [Abstract] [Full Text] [Related]

  • 3. Impaired TLR-2 expression and TLR-2-mediated cytokine secretion in macrophages from patients with atopic dermatitis.
    Niebuhr M, Lutat C, Sigel S, Werfel T.
    Allergy; 2009 Nov; 64(11):1580-7. PubMed ID: 19392987
    [Abstract] [Full Text] [Related]

  • 4. Intrinsic alterations of pro-inflammatory mediators in unstimulated and TLR-2 stimulated keratinocytes from atopic dermatitis patients.
    Niebuhr M, Heratizadeh A, Wichmann K, Satzger I, Werfel T.
    Exp Dermatol; 2011 Jun; 20(6):468-72. PubMed ID: 21447101
    [Abstract] [Full Text] [Related]

  • 5. Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3.
    Kulka M, Alexopoulou L, Flavell RA, Metcalfe DD.
    J Allergy Clin Immunol; 2004 Jul; 114(1):174-82. PubMed ID: 15241362
    [Abstract] [Full Text] [Related]

  • 6. Selective impairment of Toll-like receptor 2-mediated proinflammatory cytokine production by monocytes from patients with atopic dermatitis.
    Hasannejad H, Takahashi R, Kimishima M, Hayakawa K, Shiohara T.
    J Allergy Clin Immunol; 2007 Jul; 120(1):69-75. PubMed ID: 17531301
    [Abstract] [Full Text] [Related]

  • 7. Monocyte-derived dendritic cells from highly atopic individuals are not impaired in their pro-inflammatory response to toll-like receptor ligands.
    Terhorst D, Kalali BN, Weidinger S, Illig T, Novak N, Ring J, Ollert M, Mempel M.
    Clin Exp Allergy; 2007 Mar; 37(3):381-90. PubMed ID: 17359388
    [Abstract] [Full Text] [Related]

  • 8. The expression of toll-like receptors 3 and 7 in rheumatoid arthritis synovium is increased and costimulation of toll-like receptors 3, 4, and 7/8 results in synergistic cytokine production by dendritic cells.
    Roelofs MF, Joosten LA, Abdollahi-Roodsaz S, van Lieshout AW, Sprong T, van den Hoogen FH, van den Berg WB, Radstake TR.
    Arthritis Rheum; 2005 Aug; 52(8):2313-22. PubMed ID: 16052591
    [Abstract] [Full Text] [Related]

  • 9. Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity?
    Candia L, Marquez J, Hernandez C, Zea AH, Espinoza LR.
    J Rheumatol; 2007 Feb; 34(2):374-9. PubMed ID: 17183618
    [Abstract] [Full Text] [Related]

  • 10. Low neonatal Toll-like receptor 4-mediated interleukin-10 production is associated with subsequent atopic dermatitis.
    Belderbos ME, Knol EF, Houben ML, van Bleek GM, Wilbrink B, Kimpen JL, Rovers M, Bont L.
    Clin Exp Allergy; 2012 Jan; 42(1):66-75. PubMed ID: 22092594
    [Abstract] [Full Text] [Related]

  • 11. Shift from toll-like receptor 2 (TLR-2) toward TLR-4 dependency in the erosive stage of chronic streptococcal cell wall arthritis coincident with TLR-4-mediated interleukin-17 production.
    Abdollahi-Roodsaz S, Joosten LA, Helsen MM, Walgreen B, van Lent PL, van den Bersselaar LA, Koenders MI, van den Berg WB.
    Arthritis Rheum; 2008 Dec; 58(12):3753-64. PubMed ID: 19035506
    [Abstract] [Full Text] [Related]

  • 12. Hyper-IgE syndrome is not associated with defects in several candidate toll-like receptor pathway genes.
    Hawn TR, Ozinsky A, Williams LM, Rodrigues S, Clark A, Pham U, Hill HR, Ochs H, Aderem A, Liles WC.
    Hum Immunol; 2005 Jul; 66(7):842-7. PubMed ID: 16112032
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Dysregulation of CD36 upon TLR-2 stimulation in monocytes from patients with atopic dermatitis and the TLR2 R753Q polymorphism.
    Niebuhr M, Langnickel J, Sigel S, Werfel T.
    Exp Dermatol; 2010 Aug; 19(8):e296-8. PubMed ID: 19849713
    [Abstract] [Full Text] [Related]

  • 15. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A, Li L, Giannopoulos K, Greiner J, Reinhardt P, Wiesneth M, Schmitt M.
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [Abstract] [Full Text] [Related]

  • 16. Decreased expression of Toll-like receptor 2 and 4 on macrophages in experimental severe acute pancreatitis.
    Matsumura N, Takeyama Y, Ueda T, Yasuda T, Shinzeki M, Sawa H, Nakajima T, Kuroda Y.
    Kobe J Med Sci; 2007 May; 53(5):219-27. PubMed ID: 18204298
    [Abstract] [Full Text] [Related]

  • 17. Functional effects of interleukin 31 in human primary keratinocytes.
    Kasraie S, Niebuhr M, Baumert K, Werfel T.
    Allergy; 2011 Jul; 66(7):845-52. PubMed ID: 21261663
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptor heterodimer variants protect from childhood asthma.
    Kormann MS, Depner M, Hartl D, Klopp N, Illig T, Adamski J, Vogelberg C, Weiland SK, von Mutius E, Kabesch M.
    J Allergy Clin Immunol; 2008 Jul; 122(1):86-92, 92.e1-8. PubMed ID: 18547625
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Toll-like receptor 2 ligands promote chronic atopic dermatitis through IL-4-mediated suppression of IL-10.
    Kaesler S, Volz T, Skabytska Y, Köberle M, Hein U, Chen KM, Guenova E, Wölbing F, Röcken M, Biedermann T.
    J Allergy Clin Immunol; 2014 Jul; 134(1):92-9. PubMed ID: 24698321
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.